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Abstract 
 
Repeatability of Impedance Cardiography Hemodynamic Variables During Treadmill Exercise  
Purpose To analyze the day to day repeatability of cardiac hemodynamic measurements using a 
Physio Flow 07 Enduro during treadmill submaximal exercise.  
Methods 21 male subject ages 18 and older were studied. Two graded treadmill exercise tests 
consisting of two 5-minute steady state stages (Moderate and Vigorous intensity) were 
performed using the PhysioFlow device at least 48 hours apart.  Cardiac hemodynamic 
measurements were compared between stages and trials using repeated measures ANOVA, 
intraclass correlations, and Bland-Altman plots.  
Results Oxygen consumption (VO2) and respiratory exchange ratio (RER), were not different 
between the two trials for either Moderate or Vigorous intensities. There was a main effect for 
intensity for all variables with the exception early diastolic filling ratio (EDFR) and ejection 
fraction (EF%). Intraclass correlation coefficients between exercise trials were > 0.7 for all 
hemodynamic variables except for ventricular ejection time (VET) (Moderate and Vigorous 
Intensity stages), and EDFR (Moderate Intensity Stage). Coefficient of Variation between 
exercise trials were <12.5% for all hemodynamic variables and <8% for primary hemodynamic 
variables. Bland-Altman analysis showed good agreement (P >0.05) for all hemodynamic 
measures except heart rate (HR) (P = 0.018 and 0.019 for Moderate Intensity Stage and Vigorous 
Intensity Stage, respectively), left cardiac work index (LCWi) (Vigorous Intensity Stage, P = 
0.000), and systemic vascular resistance index (SVRi) (Vigorous Intensity Stage, P = 0.000). 
Conclusion Measurements from the PhysioFlow was repeatable, with no statistical differences 
across trials and reasonably strong reliability coefficients for most relevant hemodynamic 
variables, apart from VET and Low Intensity Stage EDFR, during moderate and vigorous 
intensity treadmill exercise.  
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Keywords: PhysioFlow, Impedance Cardiography, hemodynamic variables, cardiac output, 
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Chapter I 
Introduction 
 The study of hemodynamics is a branch of physiology that characterizes the forces and 
physical aspects that affect the circulation of oxygenated blood.  Cardiac output and stroke 
volume are two critical components of circulation and describe cardiovascular function.  Cardiac 
output measures the amount of blood pumped by the ventricles each minute and is the primary 
indicator of the functional capacity of the circulation to meet the increased demands during 
physical activity. Cardiac output, the product of stroke volume and heart rate, is also one of the 
most basic means for assessing cardiac function and hemodynamics (Pickett, 1992).  A healthy 
heart will pump 4-8 liters of blood per minute at rest.  Untrained individuals have an average 
maximum cardiac output of 14 to 20 L/min and extremely trained individuals can reach 
measurements of up to 40 L/min (Powers, 2014). When an individual is resting they have an 
average heart rate of 60-100bpm. Resting stroke volume is 60-100 milliliters per beat on average, 
however it is possible that all of these hemodynamic measurements will vary based on the 
training level of an individual (Powers, 2014).  Changes in stroke volume, heart rate and other 
factors influencing cardiac output vary considerably during exercise and under different health 
and disease conditions; therefore accurate measurements of cardiac output and stroke volume are 
very important for both clinical and exercise purposes (Charloux, 2000).   
Hemodynamic measurements are commonly used for clinical purposes and contribute to 
the understanding of the pathophysiology behind diseases. These measurements are also 
applicable in high-risk patients undergoing surgery as well as critically ill, medically treated 
patients.  Hemodynamic measurements, such as cardiac output and stroke volume can accurately 
determine heart function, and measure the continuously changing function of the heart as related 
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to the process of a disease. These measurements can guide treatments and interventions based on 
a rational physiologic source, therefore aiding in the prognosis and therapy plans for patients 
(Swan, 1983).   
Hemodynamic measurements are also important in exercise physiology research and 
exercise testing.  Results can be used for multiple purposes such as exercise prescription and 
clinical diagnosis. Jennings et al (1986) used hemodynamic measurements during exercise to 
assess the effect of changes in physical activity on major cardiovascular risk factors, 
hemodynamics, sympathetic function, and glucose utilization in men. An indirect Fick method 
and mixed venous partial pressure of carbon dioxide (pCO2) by a carbon dioxide rebreathing 
method were used to measure cardiac output.  By studying hemodynamics and other factors 
during exercise, this study found that increasing physical activity in young sedentary normal 
adults would decrease risk of a chance for subsequent development of cardiovascular disease 
(Jennings, 1986).   
Previous techniques for measuring hemodynamic principles are complicated, invasive, 
and typically require trained personnel.  As a result, they are highly impractical. The criterion 
technique developed for measuring cardiac output is known as the Fick Method.  This method 
determines cardiac output from the direct measurements of oxygen content of arterial and mixed 
venous blood as well as measurements of oxygen consumption (VO2). This technique was first 
utilized in 1940 to determine the cardiac output of a man before and after a blood transfusion 
surgery (Laszlo, 2004). The Fick method requires that arterial blood samples from the arterial 
line and mixed venous blood samples from the distal pulmonary arterial opening are obtained 
simultaneously using a catheter.  From this sample partial pressure of oxygen (pO2), partial 
pressure of carbon dioxide (pCO2), pH, and base excess can be determined.  Arterial and mixed 
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venous oxygen consumptions are then calculated as the product of hemoglobin, the hemoglobin-
binding constant of oxygen (1.34g/L), and oxygen saturation because most of the oxygen in 
arterial blood is bound to hemoglobin.  Oxygen consumption (VO2) and the amount of carbon 
dioxide exhaled (VCO2) are measured by a breath-by-breath analysis (Hoeper, 1999). Cardiac 
output (Q) is then calculated according to the formula: 
Q=VO2/(CaO2-CvO2) 
In this equation, VO2 represent oxygen consumption, CaO2 is the measured oxygen concentration 
of arterial blood, and CvO2 is the measured oxygen concentration of mixed venous blood.  
Because this technique requires catheterization of the pulmonary arterial circulation, it is 
highly invasive for the individual. The indirect Fick method uses an estimated value for mixed 
venous gas pressure and blood-gas contents, which are derived from known partial pressures of 
the gas in the blood (Laszlo, 2004).  The accepted standard for measuring cardiac output was 
considered the direct Fick method until other hemodynamic monitoring methods were later 
developed.  Another strategy is the dye dilution technique. For this technique, cardiac output is 
measured by rapidly injecting a known amount of dye into one site of the circulatory system and 
withdrawing blood at the distal end of the system. This method uses an equation to calculate 
cardiac output, which is defined by dividing the indicated amount of an injected dye by the area 
under the dilution curve measured downstream (Lund- Johansen, 1990). Studies found that the 
dye dilution technique is just as reliable as the Fick method and it was later noted this dye 
dilution method could also be used during exercise (Taylor, 1966; Lund- Johansen, 1990). In 
1953, heat was used as a substitute for dye indicator for a new thermodilution technique. A 
solution that is colder than the blood in circulation is injected intravenously and thermocouples 
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are placed in the right ventricle and thoracic aorta record temperature changes in the blood 
(Fegler, 1957).  The cardiac output can then be calculated from the thermodilution curves.   
The invention of the right heart catheterization also known as the Swan-Ganz catheter, 
significantly influenced the development of cardiac output monitoring.  The most trusted method 
for hemodynamic measurements and clinical diagnostic purposes has been the invasive 
pulmonary artery catheterization-based thermodilution technique and is typically used as 
comparison for new hemodynamic monitoring devices (Borlaug, 2009; Pugsley, 2010). 
However, this technique holds many possible risks.  It does not allow the individual to move or 
exercise and may even require a hospital stay (Jones, 2011).  Therefore, non-invasive techniques 
could greatly enhance the ability to measure these hemodynamic variables.  
The most practical non-invasive methods for measuring cardiac output are Doppler 
echocardiography, partial rebreathing indirect Fick method, and impedance cardiography; 
however their accuracy and repeatability during exercise is still uncertain (Charloux, 2000).  
During the Doppler echocardiography method, the aortic diameter is measured using a pulsed 
ultrasound. A continuous-wave Doppler ultrasound is used to obtain the aortic blood velocity 
(Huntsman, 1983).  Cardiac output can be calculated through the measurement of aortic blood 
velocity without requiring aortic size measurements (Haites, 1985). It was found that this 
technique is reliable when used during submaximal and peak exercise (Shaw, 1985).  A study 
comparing the Doppler ultrasound method and the thermodilution catheterization method found 
that the assessment of cardiac output via non-invasive techniques compared to cardiac output 
measurements using invasive catheterization techniques were entirely consistent with previous 
published work, which showed validity (Huntsman, 1983).    
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The partial rebreathing technique uses a differentiated form of the Fick equation to 
calculate cardiac output.  Changes in carbon dioxide (CO2) removal and partial pressure of end-
tidal CO2 measurements as a result of partial rebreathing are used to estimate the measurement 
for the pulmonary capillary blood flow.  It is assumed that the mixed venous CO2 content does 
not change during a brief change in ventilation. Oxygen saturation and inspired oxygen 
concentration measurements are then incorporated into the equation to calculate the total cardiac 
output (Haryadi, 2000).   
Impedance cardiography has been advancing for over 40 years and has been used to 
monitor overall cardiac function.  The original impedance design consisted of a configuration of 
four band electrodes with two electrodes placed around the neck and two placed on around the 
abdomen. One inner electrode is place around the base of the neck and the other is between the 
xiphoid process and sternum.  The inner electrodes are the sensing electrodes and pick up the 
signals put out by the outer electrodes.  The outer electrodes are placed at least three centimeters 
outside the inner electrodes in order to obtain proper readings and conduct a small current.  This 
continuous current is conducted through the chest electrodes starting from the top outer neck 
electrode.  A voltage drop is generated between the inner neck electrode and the inner abdomen 
electrode.  This voltage is recognized by the impedance amplifiers, which obtain a value for the 
magnitude of the impedance in ohms.  The value can then be derived to calculate ventricular 
stroke volume and cardiac output.  The stroke volume equation is:  
SV= p (L/Z0)2 (dZ/dt max) (LVET) 
In this equation, the resistivity of blood in ohms is represented by p (ohms), L (cm) is the 
distance between the neck inner sensing electrode and the abdominal inner sensing electrode, Z0 
(ohms) represents the average body impedance between the neck inner electrode and the 
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abdominal inner electrode, dZ/dt (ohms/second) the first derivative of change in impedance in 
the thorax region, and LVET (sec) represents the time it takes for the left ventricle to eject its 
blood during systole (Kubicek, 1970). Multiple research studies have been performed using 
alterations to the basic concept of impedance for measuring cardiac output and other 
hemodynamic measurements for both exercise and clinical purposes.  
A newer model of impedance cardiography called PhysioFlow uses a modified equation 
to calculate hemodynamic measurements.  This device is based on the equation: 
CO=fc * SV index * BSA 
In this equation, fc is the heart rate in beats per minute, BSA is the body surface area in meters 
squared and is calculated according to the Haycock formula (BSA=0.024265 x body mass in 
kg0.5378 x Height in cm0.3964).  SV index is measured in ml/m2 and is determined by dividing the 
stroke volume by the surface area of the body (Charloux, 2000). The PhysioFlow device is 
designed to have enhanced signaling, making it capable to provide better data processing.  A 
study comparing measurements of cardiac output during submaximal exercise in healthy adults 
using the PhysioFlow device and the direct Fick method found high correlation between these 
two methods and accurate measurements of cardiac output using the new impedance PhysioFlow 
device.  Cardiac output was recorded at rest and during cycle exercise at 10 to 50Watts.  The 
PhysioFlow cardiac output measurements were from 4.34 to 14.841L/min and the Direct Fick 
method had cardiac output measurements of 3.60-15.03 L/min (Charloux, 2000).  
A subsequent study tested the reproducibility and accuracy of the PhysioFlow device in 
moderately trained, healthy subjects performing identical graded maximal exercise tests on an 
electronically braked bicycle ergometer on two separate occasions, three days apart. In a 
subgroup of seven subjects, cardiac output was measured using the direct Fick method in parallel 
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with the PhysioFlow to test for accuracy and concluded that the PhysioFlow can produce 
clinically accurate measurements during incremental maximal exercise (Richard, 2001). A 
different study compared PhysioFlow cardiac output measurements during different exercise 
intensities to the CO2 rebreathing technique.  There were no significant differences with the 
PhysioFlow cardiac output measurement and the CO2 rebreathing cardiac output measurements 
during mild to high intensity steady-state exercises on a cycle ergometer (Tordi, 2004).  Another 
study aimed to assess the reproducibility of cardiac output and hemodynamic parameters from 
impedance cardiography via PhysioFlow during resting positions of supine, seating and standing 
and during light to moderate steady-state exercise on a cycle ergometer. Both resting and 
exercise positions had an intraclass correlation coefficient (ICC) > 0.7 for all variables (Schulz, 
2012). Based on previous research, it is apparent that the PhysioFlow makes measuring CO and 
other hemodynamic factors during exercise easier, however the repeatability of this device 
during other modes of exercise, including treadmill exercise, is still unknown.   
The purpose of this study was to analyze day to day repeatability of cardiac 
hemodynamic measurements using a PhysioFlow device (PhysioFlow 07 Enduro) during 
submaximal treadmill exercise.  Due to the research on the accuracy of this equipment, it was 
hypothesized that the PhysioFlow measurements would demonstrate good consistency between 
repeated submaximal treadmill exercise. If this device proves to be repeatable, it has potential to 
be a new non-invasive standard for hemodynamic measuring during both exercise and clinical 
situations.   
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Chapter II 
Methodology 
Subjects: 
 The study aimed to obtain a sample of 15 to 30 male students from James Madison 
University and the Harrisonburg community who were 18 years or older.  Recruitment of subject 
was via JMU bulk email requests and through word-of-mouth. Individuals with previous 
diagnosis of cardiovascular, pulmonary, or metabolic disease, as well as individuals who are not 
capable of vigorous exercise intensity due to an orthopedic limitation were excluded from 
participation.  Individuals taking medications that impact cardiovascular hemodynamics were 
omitted.  All procedures were approved by the Institutional Review Board (IRB).  
Pre-test 
 Following completion of a signed informed consent form, subjects were asked to 
complete two questionnaires, which were sent via online links.  The first questionnaire, the 
Physical Activity Readiness Questionnaire (PARQ), is a short 7-question assessment to identify 
reasons the individual should not participate in moderate-to-vigorous exercise (Pescatello, 2014).  
The second questionnaire is the International Physical Activity Questionnaire Short Form 
(IPAQ).  This is a validated questionnaire to assess physical activity levels in a subjective 
manner (Ekelund, 2006). 
Testing Procedure: 
 After completing necessary paperwork, the subject’s height and weight were measured.  
Weight measurements were recorded to the nearest 0.1kg using a physician’s scale and height 
was measured and recorded to the nearest 0.5cm using a wall stabilized stadiometer.  The subject 
was then prepped for the PhysioFlow device by shaving and/or cleaning the electrode placement 
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sites in order to prevent interference. A resting blood pressure measurement was obtained prior 
to exercise using a stethoscope and blood pressure cuff. Blood pressure procedures followed 
ACSM procedures describes in the ACSM’s Guidelines for Exercise Testing and Prescription 
(Pescatello, 2014).    
 The subjects then completed a maximal graded exercise test on the treadmill utilizing a 
standardized ramped protocol developed specifically for this study. The test began with a one 
minute walking stage at 2.6 mph and 0% grade (3 METs) and progressed to a second one minute 
walking stage at 3.1 mph and 1.5% grade (4 METs).  The subject then entered their first five 
minute- modereate intensity steady state stage at 3.6 mph and 2.5% (5 METs). Three minutes 
into this stage blood pressure was measured and entered into the PhysioFlow software. After this 
five minute stage, the subjects entered a one minute stage at 4 mph and 3.5% grade (6 METs).  
They then entered their second five minute-vigorous intensity steady state stage at 4mph and 
5.5% grade (7 METs).  Another blood pressure measurement was taken and recorded three 
minutes into this stage. At the end of the second five-minute stage, speed and/or grade increased 
each minute until the subject reached voluntary fatigue, could no longer physically continue, or 
experienced adverse signs or symptoms. Oxygen consumption (VO2) was measured continuously 
throughout the test with a metabolic cart (Parvo Medics TrueOne 2400) indirect calorimetry 
system.  After the initial maximal graded exercise test, subjects were asked to return to the 
human performance lab on a subsequent day after a minimum two day recovery period. Testing 
was conducted at the same time of day in order to eliminate any diurnal influence on 
hemodynamic measures. On the subsequent testing date a second maximal treadmill test was 
conducted, using the same procedure described above. 
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Hemodynamic Measurement  
 A PhysioFlow 07 Enduro (impedance cardiography device) was used to monitor 
hemodynamic measurements. These measurements include stroke volume (mL), stroke volume 
index (mL/m2), heart rate (bpm), cardiac output (L/min), cardiac output index (L/min/m2), 
contractility index, ventricular ejection time (ms), end diastolic filling ratio (%), left cardiac 
work index (kg∙m/m2), systemic vascular resistance (dyn.s/cm5), systemic vascular resistance 
index (dyn∙s/cm5∙m2), end diastolic volume est (mL), ejection fraction est (%), mean arterial 
pressure (mmHg) and rate pressure product (mmHg∙bpm).   
 Heart rate (HR) measures the amount of times the heart beats per minute. Stroke volume 
index (SVi) divides the stroke volume (SV) value, which is the amount of blood pumped per 
beat, corrected for body surface area.  Similarly, Cardiac output (CO) measures the volume of 
blood pumped by the heart each minute, and cardiac output index (COi) divides this values by 
the body surface area.  Left cardiac work index (LCWi) represents the amount of work the left 
ventricle must perform each minute in order to pump the blood out to the aorta and is normalized 
for the individual body surface area.  Systemic vascular resistance (SVR) is the resistances to 
blood flow from all of the systemic vasculature, and systemic vascular resistance index (SVRi) is 
the measurement relative to the individual’s body surface area.  End diastolic volume (EDV) is 
the amount of blood in the ventricles just prior to systole.  Contractility index (Ci) represents the 
contractile ability of the heart.  Early diastolic filling ratio (EDFR) is the ratio of early to late 
ventricular filling velocities and can determine the functional ability of the left ventricle of the 
heart.  Ventricular ejection time (VET) measures the time it takes for the left ventricle to pump 
blood in one beat and ejection fraction (EF) is the percentage of blood leaving the heart in one 
pump. Mean arterial pressure (MAP) represents the “afterload” or the pressure that the left 
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ventricle must exceed in order to pump blood out of the aorta.  Rate pressure product (RPP) 
measures the workload of the heart.  
Analysis:  
 Repeated measures ANOVA, intraclass correlations, and Bland-Altman plots were 
employed to determine mean differences, agreement and repeatability of the hemodynamic 
variables at the two absolute submaximal intensities.  
Timeline: 
 Recruitment of subjects began in April 2016. The recruitment continued throughout 
November 2016 until a total of 21 college aged male subjects completed the study.  Each subject 
reported to the Human Performance Lab on the campus of James Madison University to 
complete the study protocol.  The completion date for data collection was April 2017.   
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Chapter III 
Manuscript 
Repeatability of Impedance Cardiography Hemodynamic Variables During Treadmill Exercise  
Abstract 
 
Purpose To analyze the day to day repeatability of cardiac hemodynamic measurements using a 
Physio Flow 07 Enduro during treadmill submaximal exercise.  
Methods 21 male subjects, ages 21.4 ± 0.5	  were studied. Two graded treadmill exercise tests 
consisting of two 5-minute steady state stages (Moderate and Vigorous intensity) were 
performed using the PhysioFlow device at least 48 hours apart.  Cardiac hemodynamic 
measurements were compared between stages and trials using repeated measures ANOVA, 
intraclass correlations, and Bland-Altman plots.  
Results Oxygen consumption (VO2) or respiratory exchange ratio (RER), obtained from the 
Parvo Medics TrueOne 2400, were not different between the two trials for either Moderate or 
Vigorous intensity steady-state stage. There was a main effect for intensity for all variables with 
the exception early diastolic filling ratio (EDFR) and ejection fraction (EF%). Intraclass 
correlation coefficients between exercise trials were > 0.7 for all hemodynamic variables except 
for ventricular ejection time (VET) (Moderate and Vigorous Intensity stages), and EDFR 
(Moderate Intensity Stage). Coefficient of Variation between exercise trials were <12.5% for all 
hemodynamic variables and <8% for primary hemodynamic variables. Bland-Altman analysis 
showed good agreement (P >0.05) for all hemodynamic measures except heart rate (HR) (P = 
0.018 and 0.019 for Moderate Intensity Stage and Vigorous Intensity Stage, respectively), left 
cardiac work index (LCWi) (Vigorous Intensity Stage, P = 0.000), and systemic vascular 
resistance index (SVRi) (Vigorous Intensity Stage, P = 0.000). 
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Conclusion Measurements from the PhysioFlow was repeatable, with no statistical differences 
across trials and reasonably strong reliability coefficients for most relevant hemodynamic 
variables, apart from VET and Low Intensity Stage EDFR, during moderate and vigorous 
intensity treadmill exercise.  
Keywords: PhysioFlow, Impedance Cardiography, hemodynamic variables, cardiac output, 
stroke volume, non-invasive 
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Introduction  
Changes in stroke volume (SV), heart rate (HR) and other hemodynamic factors 
influencing cardiac output (CO) vary considerably during exercise and under different health and 
disease conditions; therefore accurate measurements of cardiac output and stroke volume are 
very important for both clinical and exercise purposes (Charloux, 2000).  The Fick Method, a 
criterion technique for assessing these variables, requires arterial blood samples and is therefore 
an invasive procedure (Hoeper, 1999). Thus, accurate and reliable methods for non-invasively 
determining hemodynamic variables would be of practical significance.  
The most practical non-invasive methods for measuring CO are Doppler 
echocardiography, partial rebreathing indirect Fick method, and impedance cardiography; 
however their accuracy and repeatability during exercise is still uncertain (Charloux, 2000). It 
was found that the Doppler echocardiography technique is reliable when used during 
submaximal and peak exercise (Shaw, 1985). The partial rebreathing technique uses changes in 
carbon dioxide (CO2) removal and partial pressure of end-tidal CO2 measurements as a result of 
partial rebreathing to estimate the measurement for the pulmonary capillary blood flow. Oxygen 
saturation and inspired oxygen concentration measurements are then incorporated into the 
equation to calculate the total cardiac output (Haryadi, 2000).   
Impedance cardiography is a noninvasive technology that measures the total electrical 
conductivity of the thorax and its changes in time to process cardiodynamic parameters. Day to 
day variations in physiology can also influence impedance cardiography by +/- 4.6% for CO and 
+/- 6.1% for SV (Ng, 1991).  More recently, a newer model of impedance cardiography, called 
PhysioFlow, has been designed to have enhanced signaling, making it capable to provide better 
data processing.  A study comparing measurements of CO during submaximal exercise in 
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healthy adults using the PhysioFlow device and the direct Fick method found high correlation 
between these two methods and accurate measurements of CO during cycle exercise using the 
new impedance PhysioFlow device (Charloux, 2000). A subsequent study tested the 
reproducibility and accuracy of the PhysioFlow device in moderately trained, healthy subject 
performing identical graded maximal exercise tests on a cycle ergometer on two separate 
occasions, three days apart. In a subgroup of seven subjects, cardiac output was measured using 
the direct Fick method in parallel with the PhysioFlow to test for accuracy and concluded that the 
PhysioFlow can produce clinically accurate measurements during incremental maximal exercise 
on a bicycle (Richard, 2001). Furthermore, a prior study found no significant differences 
between PhysioFlow CO measurement and the CO2 rebreathing cardiac output measurements 
during mild to high intensity steady-state exercises on a cycle ergometer (Tordi, 2004).  Another 
study observed intraclass correlation coefficients (ICC) > 0.7 for several hemodynamic variables 
for repeated PhysioFlow measurements during resting positions of supine, seated and standing 
and during light to moderate steady-state exercise on a cycle ergometer. (Schulz, 2012). Based 
on previous research, it is apparent that the PhysioFlow makes measuring CO and other 
hemodynamic factors during cycle ergometer exercise easier, however the repeatability of this 
device during other modes of exercise, including treadmill exercise, has not been explored.   
The purpose of this study was to analyze day to day repeatability of cardiac 
hemodynamic measurements using a PhysioFlow device (PhysioFlow 07 Enduro) during 
submaximal treadmill exercise.  It was hypothesized that the PhysioFlow measurements would 
demonstrate good consistency between repeated submaximal treadmill trials.  
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Materials and Methods 
Subjects: 
 21 male students ages 21.4 ± 0.5 were recruited from James Madison University and the 
Harrisonburg community via email and word of mouth. Individuals with previous diagnosis of 
cardiovascular, pulmonary, or metabolic disease, as well as individuals who are not capable of 
vigorous exercise intensity due to an orthopedic limitation were excluded from participation.  
Individuals taking medications that impact cardiovascular hemodynamics were also omitted.  
Procedures were approved by the Institutional Review Board (IRB).  
Testing Procedure: 
 Subjects completed a maximal graded exercise test on the treadmill utilizing a 
standardized ramping protocol developed specifically for this study (Table 1). The test began 
with a one minute walking stage at 3 METs and progressed to a second one minute walking stage 
at 4 METs.  The subject then entered a five minute- Moderate Intensity steady state stage at 5 
METs. Three minutes into this stage, blood pressure was measured and entered into the 
PhysioFlow software. After this five-minute stage (Moderate Intensity Stage), the subjects 
completed a one-minute stage at 6 METs, followed by a five minute-Vigorous intensity steady 
state stage (Vigorous Intensity Stage) at 7 METs. Another blood pressure measurement was 
taken and recorded three minutes into this stage. At the end of the second five-minute stage, 
speed and/or grade increased each minute until the subject reached voluntary fatigue, could no 
longer physically continue, or experienced adverse signs or symptoms, in order to quantify their 
VO2 Max. Oxygen consumption was measured continuously throughout the test with a breath-
by-breath (TrueOne 2400, Parvo Medics, Sandy, UT) indirect calorimetry system.  After the 
initial graded exercise test, subjects were asked to return to the human performance lab on a 
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subsequent day after a two day recovery period. Testing was conducted at the same time of day 
in order to eliminate any diurnal influence on hemodynamic measures. On the subsequent testing 
date, a second maximal treadmill test was conducted using the same procedure described above. 
Hemodynamic Measurement  
 A PhysioFlow 07 Enduro (impedance cardiography device) was used to monitor 
hemodynamic measurements. These measurements included stroke volume (SV), stroke volume 
index (SVi), heart rate (HR), cardiac output (CO), cardiac output index (COi), contractility 
index, ventricular ejection time (VET), early diastolic filling ratio (EDFR), left cardiac work 
index (LCWi), systemic vascular resistance (SVR),  systemic vascular resistance index (SVRi), 
end diastolic volume (EDV),  ejection fraction (EF), mean arterial pressure (MAP) and rate 
pressure product (RRP).    
Analysis:  
 Repeated measures ANOVA, intraclass correlations, and Bland-Altman plots were 
employed to determine mean differences, agreement and repeatability of the hemodynamic 
variables at the two steady state submaximal intensities.  All statistical analyses were carried out 
using SPSS Statistical Package version 24.0 (IBM Corp., Armonk, NY).  Statistical significance 
was set a priori at P < 0.05. 
Results  
 Subject characteristics are in Table 1. As expected, VO2 and RER increased during the 
two exercise trials as the intensity increased, but there was no statistical difference in VO2 or 
RER between the two trials for either moderate or vigorous steady-state stages. For the 
PhysioFlow derived hemodynamic variables, there was a main effect for intensity for all 
variables with the exception EDFR (significant interaction for intensity and trial, P = 0.013) and 
	   XXV	  
EF% (no significant main effects).  For HR, there was a significant main effect for trial (P = 
0.013), with Trial 1 heart rates significantly higher for both stages.  For all other hemodynamic 
variables, there was no statistical difference between exercise trials. Mean values for 
hemodynamic and exercise variables can be found in Table 3.  
 Intraclass correlation coefficients between exercise trials were > 0.7for all hemodynamic 
variables except for VET (both stages), and EDFR (Moderate Intensity Stage). Table 4 presents 
Intraclass correlation coefficient, standard errors of the estimate, and coefficient of variation.  
Coefficient of Variations were <12.5% for all hemodynamic measurements and <8% for all 
primary hemodynamic measurements (Table 4). Bland-Altman analysis showed good agreement 
(P >0.05) for all hemodynamic measures except HR (P = 0.018 and 0.019 for Moderate Intensity 
Stage and Vigorous Intensity Stage, respectively), LCWi (Vigorous Intensity Stage, P = 0.000), 
and SVRi (Vigorous Intensity Stage, P = 0.000). Figures 1-4 display Bland-Altman plots for CO, 
SV, HR, and SVR.  
Discussion 
 This study was designed to test the repeatability of measurements obtained from 
PhysioFlow impedance cardiography during moderate and vigorous treadmill exercise. Overall, 
it appears that the PhysioFlow demonstrated good consistency for most hemodynamic 
measurements during treadmill exercise, with the exception of EDFR and VET, when 
considering mean differences and ICC data. There was no significant difference in VO2 or RER 
between the two trials for either stage, indicating that the subjects exercised as the same 
workload on both days. There was an increase in VO2, SV, HR, CO, CI, EDV, CTi, VET, and 
LCWi with increased intensity, which was to be expected. The only variables that did not 
increase as intensity increased for were EDFR and EF%. For TM1, there was no statistical 
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difference in CTi, BP, or ESV between Moderate Intensity Stage and Vigorous Intensity stage, 
therefore EDFR did not increase. For TM2, there was a statistical difference in CTi between 
stages, no statistical difference in BP, and no statistical difference in ESV. It is expected to see 
an increase in EDFR for TM2 based off the proposed mechanisms, therefore a possible 
explanation could be device error (Sengupta, 2008).  
In a previous study, Charloux found the PhysioFlow device to be reliable at rest and 
during cycle exercise at 10 to 50 Watts by comparing this device to the Direct Fick Method using 
catheterization (Charloux, 2000). Another study found the PhysioFlow to produce clinically 
accurate measurements during incremental, maximal cycle exercise (Richard, 2001). Schultz 
validated the PhysioFlow during supine, seated and standing positions with intraclass correlation 
coefficient  > 0.7 for all hemodynamic variables in each posture, as well as each intensity of 
exercise.  Shultz’s study also showed reliable measurements during light to moderate steady-
state exercise on a cycle ergometer (Shultz, 2012). The present study is the first to investigate the 
PhysioFlow’s reproducibility in incremental and steady-state treadmill exercise.  
The aforementioned study from Richard evaluated the reproducibility of the device using 
an incremental, maximal cycle test. This is different from the present study, which used the final 
two minutes of a five minute steady state stage.  Overall, Richard’s results produced clinically 
accurate measurements, as validated by comparing to the Direct Fick method, and had a 
reliability coefficient  of r=0.95 for CO on different days and a validity coefficient of r=0.94 
(Richard, 2001). Shultz examined measurements obtained for five minutes once the subject 
reached steady state with first minute of steady state data used for analysis. The authors reported 
that all ICC’s were above 0.7 for each variable at each intensity of cycle exercise, which were 
similar intensities to that of the present study (Shultz, 2012).  
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The present study found that TM1 HR was significantly higher than TM2 HR, however, 
post hoc analysis showed no statistical difference in HR across trials with a given intensity. It is 
not ncommon for there to be a significant difference in HR between trials. A study comparing 
test-retest HR of males during rest, treadmill and cycle exercise found a statistical difference in 
about one-third of the pair comparisons. This group’s mean heart rate during exercise was 
significantly lower on any successive test, compared to the week prior and was noted to be lower 
at all levels of submaximal exercise during the successive test.  It was suggested that the 
decrease in HR may have been due to familiarity with the setting and the task (Sime, 1972).  
An ICC of r > 0.7 was achieved for all hemodynamic variables except VET and Moderate 
Intensity Stage EDFR. It is likely that the difference in HR between TM1 and TM2 could be the 
reason for the lack of agreement in VET, because HR is inversely related to VET (Vanfraechem, 
1979; Weissler 1961). Factors such as end systolic volume (ESV), contractility, and afterload, 
which are estimated from diastolic blood pressure (DBP), influence EDFR (Courtois, 1992; 
Moon, 1994).  When the heart contracts, the left ventricle twists as it pumps blood through the 
aorta.  During diastole, the heart muscles relax and the ventricle untwists, creating a suction 
gradient, which results in early diastolic filling. Greater contractility will produce lower ESV, 
which increases the suction gradient even more, as long as the afterload remains low (Sengupta, 
2008; Courtois, 1992).  The present study did not find evidence of statistical difference in ESV, 
CTi, or DBP that would suggest a lack of agreement between the two trials. It is possible that 
there may be a day-to-day variation in EDFR causing the low reliability coefficient, however 
future research is needed to confirm. 
A limitation in this study was that the subjects in the sample were recruited via word-of-
mouth and bulk-email requests and therefore the sample was not completely random. The 
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repeatability of the PhysioFlow is supported by the results of previous researchers.  However, the 
present study cannot validate this device due to lack of access to direct measurements.  A larger, 
more diverse sample, as well as, comparing the PhysioFlow measurements to the Direct Fick 
method could have yielded more comprehensive results.   
 In the future, researchers may wish to investigate the repeatability of the PhysioFlow 
across different modes of exercise, such as cycle and treadmill, as well as using invasive 
methods to validate their results. Overall, this study found that the PhysioFlow device was fairly 
repeatable with no statistical differences across trials and moderately strong reliability 
coefficients for most relevant hemodynamic variables, apart from VET and Moderate Intensity 
Stage EDFR, during moderate and vigorous intensity treadmill exercise.  
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Table	  1	  Subject	  Characteristics	  (n=21)	  	  	  
 Mean (±SD) 
 Age	  (years)	  	   21.4 ± 0.5	  IPAQ	  (MET⋅min⋅week-1) 	   4825.7 ± 801.1	  Height	  (cm)	  	   178.9 ± 2.0	  Weight	  (Kg)	  	   73.2 ± 2.7	  BMI	  (Kg/m2) 	   24.5 ± 0.5	  
VO2 max (mL⋅Kg-1⋅min-1) 51.5 ± 1.5 	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Table	  2	  Treadmill	  Protocol	  	  	  
Time	   TM	  Speed	  (mph)	   TM	  Grade	  (%)	  0:01-­‐0:59	   2.6	   0	  1:00-­‐1:59	   3.1	   1.5	  
2:00-­‐6:59*	   3.6	   2.5	  7:00-­‐7:59	   4	   3.5	  
8:00-­‐12:59*	   4	   5.5	  13:00-­‐13:59	   4.6	   0	  14:00-­‐14:59	   5	   1	  15:00-­‐15:59	   5.3	   2.5	  16:00-­‐16:59	   5.6	   5	  17:00-­‐17:59	   6.1	   6.5	  18:00-­‐18:59	   6	   10.5	  19:00-­‐19:59	   6	   14	  20:00-­‐20:59	   6	   16.5	  21:00-­‐21:59	   6.2	   17.5	  22:00-­‐99:59	   6.4	   18.5	  	  *Data	  collected	  in	  final	  two	  minutes	  of	  the	  given	  stage	  was	  used	  for	  analysis.	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Table	  3A.	  Mean	  Values	  of	  Primary	  Hemodynamic	  Variables	  for	  TM1	  and	  TM2.	  	  	   	   TM1	   TM2	  
Moderate Intensity Stage VO2 
(mL⋅Kg-1⋅min-1) 
19.9 ± 1.9 19.4 ± 1.5 
Vigorous Intensity Stage VO2 
(mL⋅Kg-1⋅min-1) 
 
28.7 ± 3.4† 28.3 ± 2.6† 
Moderate Intensity Stage SV 
(mL⋅beat-1) 
125.4 ± 16.4 127.6 ± 19.4 
Vigorous Intensity Stage SV 
(mL⋅beat-1) 
 
133.5 ± 17.6† 135.5 ± 22.2† 
Moderate Intensity Stage SVi 
(mL⋅beat-1⋅m2⋅-1) 
63.7 ± 7.2 64.7 ± 7.5 
Vigorous Intensity Stage SVi 
(mL⋅beat-1⋅m2⋅-1) 
 
68.7 ± 8.7† 68.5 ± 8.1† 
Moderate Intensity Stage HR 
(beats⋅min-1) 
116 ± 13 112 ± 10 
Vigorous Intensity Stage HR 
(beats⋅min-1) 
 
147 ± 15† 143 ± 13† 
Moderate Intensity Stage CO 
(L⋅min-1) 
14.4 ± 1.9 14.2 ± 2.2 
Vigorous Intensity Stage CO 
(L⋅min-1) 
 
19.7 ± 2.3† 19.4 ± 3.7† 
Moderate Intensity Stage CI 
(L⋅min-1⋅m2⋅-1) 
7.3 ± 0.7 7.2 ± 0.9 
Vigorous Intensity Stage CI 
(L⋅min-1⋅m2⋅-1) 
10.0 ± 1.0† 9.8 ± 1.4† 
 
Mean (±SD). * indicates significance of <0.05 between TM1 and TM2 trials. † indicates 
significance of <0.05 within trial due to intensity. 
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Table	  3B.	  Mean	  Values	  of	  Secondary	  Hemodynamic	  Variables	  for	  TM1	  and	  TM2.	  	  	   	   TM1	   TM2	  
Moderate Intensity Stage EDV 
(mL)	   152.8 ± 25.9	   157.6 ± 25.7	  
Vigorous Intensity Stage EDV 
(mL) 
 
161.2 ± 24.9†	   162.3 ± 29.1	  
Moderate Intensity Stage EF% 
(%) 
83.1 ± 5.6 81.5 ± 6.1 
Vigorous Intensity Stage EF% 
(%) 
 
83.4 ± 8.3 84.1 ± 6.0 
Moderate Intensity Stage SVR 
(dyn⋅s⋅cm-5) 
516.6 ± 71.1 515.6 ± 87.5 
Vigorous Intensity Stage SVR 
(dyn⋅s⋅cm-5) 
 
399.9 ± 59.6† 393.7 ± 79.6† 
Moderate Intensity Stage SVRi 
(dyn⋅s⋅cm-5⋅m2⋅-1) 
1015.0 ± 134.8 1009.2 ± 143.2 
Vigorous Intensity Stage SVRi 
(dyn⋅s⋅cm-5⋅m2⋅-1) 
 
786.0 ± 116.9† 770.4 ± 140.0† 
Moderate Intensity Stage CTi 
 
348.4 ± 66.2 353.0 ± 81.0 
Vigorous Intensity Stage CTi 
 
389.8 ± 99.4 410.9 ± 88.6† 
Moderate Intensity Stage VET 
(ms) 
254.8 ± 19.8 249.5 ± 23.4 
Vigorous Intensity Stage VET 
(ms) 
 
216.6 ± 28.2† 222.2 ± 20.8† 
Moderate Intensity Stage EDFR 
(%) 
61.0 ± 10.7 66.7 ± 14.3 
Vigorous Intensity Stage EDFR 
(%) 
 
67.4 ± 19.8 64.1 ± 16.0 
Moderate Intensity Stage LCWi 
(Kg⋅m⋅m2⋅-1) 
9.3 ± 1.4 8.9 ± 1.5 
Vigorous Intensity Stage LCWi 
(Kg⋅m⋅m2⋅-1) 
 
13.2 ± 1.8† 12.5 ± 2.6† 
 
Mean (±SD). * indicates significance of <0.05 between TM1 and TM2 trials. † indicates 
significance of <0.05 within trial due to intensity. 
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Table	  4A.	  Primary	  Intraclass correlations, Standard Errors of the Estimate, and Coefficient of 
Variation for Hemodynamic Variables between TM1 and TM2. 
 
Variable	   ICC	   p-­‐value	   SEE	   CV	  
Moderate Intensity Stage VO2 
(mL⋅Kg-1⋅min-1)	  
0.897	   <.001	   1.002	   2.7%	  
Vigorous Intensity Stage VO2 
(mL⋅Kg-1⋅min-1) 
 
0.866	   <.001	   2.179	   3.7%	  
Moderate Intensity Stage SV 
(mL⋅beat-1) 
0.857 <.001 11.030 5.0% 
Vigorous Intensity Stage SV 
(mL⋅beat-1) 
 
0.761 0.001 14.216 7.8% 
Moderate Intensity Stage SVi 
(mL⋅beat-1⋅m2⋅-1) 
0.796 <.001 5.593 5.0% 
Vigorous Intensity Stage SVi 
(mL⋅beat-1⋅m2⋅-1) 
 
0.745 0.002 7.266 6.9% 
Moderate Intensity Stage HR 
(beats⋅min-1) 
0.898 <.001 6.522 3.4% 
Vigorous Intensity Stage HR 
(beats⋅min-1) 
 
0.922 <.001 7.287 3.1% 
Moderate Intensity Stage CO 
(L⋅min-1) 
0.899 <.001 1.117 5.0% 
Vigorous Intensity Stage CO 
(L⋅min-1) 
 
0.862 <.001 1.365 7.2% 
Moderate Intensity Stage CI 
(L⋅min-1⋅m2⋅-1) 
0.837 <.001 0.535 5.0% 
Vigorous Intensity Stage CI 
(L⋅min-1⋅m2⋅-1) 
 
0.752 0.002 0.847 7.2% 
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Table	  4B.	  Secondary	  Intraclass correlations, Standard Errors of the Estimate, and Coefficient of 
Variation for Hemodynamic Variables between TM1 and TM2. 
 
Variable	   ICC	   p-­‐value	   SEE	   CV	  
Moderate Intensity Stage EDV 
(mL)	  
0.811	   <.001	   19.421	   7.4%	  
Vigorous Intensity Stage EDV 
(mL) 
 
0.848	   <.001	   17.279	   7.1%	  
Moderate Intensity Stage EF% 
(%) 
0.722 0.003 4.699 3.8% 
Vigorous Intensity Stage EF% 
(%) 
0.852 <.001 5.413 3.1% 
Moderate Intensity Stage SVR 
(dyn⋅s⋅cm-5) 
0.841 <.001 49.742 6.0% 
Vigorous Intensity Stage SVR 
(dyn⋅s⋅cm-5) 
 
0.887 <.001 34.564 6.7% 
Moderate Intensity Stage SVRi 
(dyn⋅s⋅cm-5⋅m2⋅-1) 
0.791 0.001 105.757 6.0% 
Vigorous Intensity Stage SVRi 
(dyn⋅s⋅cm-5⋅m2⋅-1) 
 
0.864 <.001 76.652 6.7% 
Moderate Intensity Stage CTi 
 
0.820 <.001 48.565 8.7% 
Vigorous Intensity Stage CTi 
 
 
0.864 <.001 64.338 10.5% 
Moderate Intensity Stage VET 
(ms) 
-0.44 0.537 20.404 7.3% 
Vigorous Intensity Stage VET 
(ms) 
 
0.614 0.02 25.713 6.9% 
Moderate Intensity Stage EDFR 
(%) 
0.620 0.011 9.553 12.4% 
Vigorous Intensity Stage EDFR 
(%) 
 
0.853 <.001 13.157 9.5% 
Moderate Intensity Stage LCWi 
(Kg⋅m⋅m2⋅-1) 
0.772 0.001 1.181 8.2% 
Vigorous Intensity Stage LCWi 
(Kg⋅m⋅m2⋅-1) 
 
0.725 0.002 1.516 10.0% 
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Figure 1A. Bland-Altman plot of Moderate Intensity Stage CO. Solid line indicates mean 
difference and dashed line indicates 2SD.  
 
 
 
 
Figure 1B. Bland-Altman plot of Vigorous Intensity Stage CO. Solid line indicates mean 
difference and dashed line indicates 2SD. 
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Figure 2A. Bland-Altman plot of Moderate Intensity Stage SV. Solid line indicates mean 
difference and dashed line indicates 2SD. 
 
 
 
 
 
 
 
Figure 2B. Bland-Altman plot of Vigorous Intensity Stage SV. Solid line indicates mean 
difference and dashed line indicates 2SD. 
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Figure 3A. Bland-Altman plot of Moderate Intensity Stage HR. Solid line indicates mean 
difference and dashed line indicates 2SD. 
 
 
 
 
 
 
 
Figure 3B. Bland-Altman plot of Vigorous Intensity Stage HR. Solid line indicates mean 
difference and dashed line indicates 2SD. 
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Figure 4A. Bland-Altman plot of Moderate Intensity Stage SVR. Solid line indicates mean 
difference and dashed line indicates 2SD. 
 
 
 
 
 
Figure 4B. Bland-Altman plot of Vigorous Intensity Stage SVR. Solid line indicates mean 
difference and dashed line indicates 2SD. 
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Cardiovascular Research at James Madison University 
Researchers at James Madison University’s Department of Kinesiology are conducting a study to 
assess the reliability of a non-invasive cardiovascular assessment device during exercise.  We are 
looking for: 
-­‐ Individuals 18 years and older 
-­‐ Not currently smoking 
-­‐ Are without significant heart, lung or metabolic disease 
-­‐ Have no serious orthopedic or bone problems that prevent vigorous exercise 
-­‐ Are on no medications 
The study would require subjects to undergo 4 maximal exercise tests, 2 on a treadmill and 2 on a 
bike, over the course of 4 visits to the James Madison University Human Performance Laboratory.  
Subjects will receive report on their aerobic fitness.  If you are interested in volunteering, please 
email the research staff.  
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James Madison University 
Department of Kinesiology 
Informed Consent 
 
Purpose 
 
You are being asked to volunteer for a research study conducted by Dr. Trent Hargens from 
James Madison University entitled, “Reliability of Impedance Cardiography in the Measurement 
of Cardiovascular Hemodynamics During Exercise”. 
 
The goal of this study is to examine whether a method for non-invasively measuring 
cardiovascular measures is repeatable on multiple days and on multiple exercise modes.   
 
Experimental Procedures 
 
You will be asked to visit the Human Performance Laboratory (HPL) in Godwin Hall 4 times 
over the course of about 2 – 4 weeks.  Your total time commitment for participation in this study 
will be about 4 hours (each visit about an hour). 
 
Upon completion of this informed consent, you will be asked to complete 2 short questionnaires, 
1 that asks about your ability to participate in physical activity, and 1 that asks about your current 
level of physical activity participation.  Each of these questionnaires should take about 5 minutes 
to complete.   
 
You will then have your height and weight measured.  Upon completion of this, you will be 
asked to complete a maximal treadmill exercise test.  During the test, researchers will monitor 
your heart rate, blood pressure and your perceived exertion to the workload you will be doing.  
You will have several electrode patches placed on your skin on your torso, back and neck.  These 
will be connected to the device measuring the variables we are interested in studying.  During the 
test, you will breathe only through a mouthpiece, with your nose clamped off, so that we can 
measure the amount of oxygen you use during exercise.  The treadmill will start with a very slow 
speed and little grade, and will steadily increase in speed and grade throughout the test, so it will 
start easy, and become very intense.  At the end of the test, it should be a best effort on your part.  
It may be as hard as any exercise you remember doing.  The exercise test will last about 10 – 15 
minutes.  Prior to your arrival to the HPL that day, you will be asked to refrain from eating for 4 
hours prior to your arrival, and to avoid caffeine and alcohol for that time period as well. 
 
Upon completion of this visit, you will be asked to return to the HPL 3 subsequent times, a 
minimum of 48 hours later, and at the same time of day as the first visit.  The remaining 3 visits 
will consist of an additional maximal treadmill test, identical to your visit 1, or a maximal cycle 
exercise test.  For the cycle test, you will be asked to pedal a cycle ergometer at a certain work 
rate that will steadily increase in difficulty until you are no longer able to maintain at least 50 
rpm.  It will start fairly easy, and become very intense, in a similar fashion to the treadmill.  We 
will measure the same things during the cycle test as we do during the treadmill test.  What type 
of test you complete (treadmill or cycle) for visits 2 – 4 will be randomized.   
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Risks 
 
There is a risk of abnormal changes during the maximal exercise tests.  These changes may 
include abnormal blood pressure, fainting, heart rhythm disorders, stroke, heart attack, and death.  
The chance of serious heart problems during maximal exercise among adults is very small (less 
than 1/10,000 maximal exercise tests).  Every effort will be made to minimize risks of an 
abnormal response by reviewing you health history and providing adequate supervision of the 
exercise test.  All staff are certified by the American Heart Association in BLS (Basic Life 
Support), and all tests will be supervised by individuals certified by the American College of 
Sports Medicine.   
 
Benefits 
 
Participation may include knowledge about your health status.  You will receive information on 
your cardiovascular fitness.  
 
Inquiries 
 
If you have any questions or concerns or you would like to receive a copy of the final aggregate 
results of this study, please contact Dr. Trent Hargens at hargenta@jmu.edu or (540) 568-5844.  
 
Questions about Your Rights as a Research Subject 
Dr. David Cockley      
Chair, Institutional Review Board    
James Madison University     
(540) 568-2834       
cocklede@jmu.edu      
 
Confidentiality 
 
All data and results will be kept confidential. You will be assigned an identification number and 
a pseudonym in place of your real name. At no time will your name be identified with your 
individual data. The researcher retains the right to use and publish non-identifiable data. All 
paper data will be kept secured in a locked cabinet in a locked office. All electronic data will be 
kept on a password-protected computer in encrypted file folders.  Upon completion of the study, 
only de-identified data will be kept for research dissemination purposes, and will be kept 
indefinitely.  All material containing identifiable information will be destroyed.  Final aggregate 
results will be made available to participants upon request. 
 
Freedom of Consent 
 
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you 
choose to participate, you can withdraw at any time without consequences of any kind. 
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I have read this consent form and I understand what is being requested of me as a participant in 
this study.  I freely consent to participate.  I have been given satisfactory answers to my 
questions.  The investigator provided me with a copy of this form I requested it.  I certify that I 
am at least 18 years of age.  By clicking "Yes" to the question below and submitting this 
confidential online survey, I am consenting to participate in this research. 
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Appendix C  
PAR-Q  
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PAR-Q & YOU 
(A questionnaire for People Aged 15-69) 
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being more active is 
very safe for most people. However, some people should check with your doctor before you start.  
 
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box below. If you 
are between the ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start. If you are over 69 years of 
age, and you are not used to being very active, check with your doctor. 
 
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one honestly: 
check YES or NO 	  
  
YES      NO  1. Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended     by a doctor? 
YES      NO  2. Do you feel pain in your chest when you do physical activity? 
YES      NO  3. In the past month, have you had chest pain when you were not doing physical activity? 
YES      NO  4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
YES      NO  5. Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a change in your      physical activity? 
YES      NO  6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition? 
YES      NO  7. Do you have a diabetes or thyroid condition? 
YES      NO   8. Do you know of any other reason why you should not do physical activity? 
 
 
If 
 
you 
 
answered 
 
“Yes”: 
YES to one or more questions 
A medical clearance form is required of all participants who answer ‘yes’ to any of the eight PAR-Q questions.   
Note: Personal training staff reserve the right to require medical clearance from any client they feel may be at risk. 
•    
Discuss with your personal doctor any conditions that may affect your exercise program. 
•    
All precautions must be documented on the medical clearance form by your personal doctor. 
 
 
NO to all questions 
If you answered NO honestly to all PAR-Q questions, you can be 
reasonably sure that you can:  
•    start becoming much more physically active - 
begin slowly and build up gradually. This is the 
safest and easiest way to go. 
•    take part in a fitness appraisal - this is an 
excellent way to determine your basic fitness so 
that you can plan the best way for you to live 
actively. It is also highly recommended that you 
have your blood pressure evaluated. If your 
reading is over 144/94, talk with your doctor 
before you start becoming much more physically 
active. 
 
 
 
DELAY	  BECOMING	  MUCH	  MORE	  ACTIVE:	  	  
•    If you are not feeling well because of a 
temporary illness such a cold or a fever - 
wait until you feel better; or 
•    If you are or may be pregnant - talk to your 
doctor before you start becoming more 
active. 
 
 
PLEASE NOTE:  If your health changes so that you then 
answer YES to any of the above questions, tell your fitness 
or health professionals. 
Ask whether you should change your physical activity plan. 
 
 
Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability to persons who undertake physical activity, and if in 
doubt after completing this questionnaire, consult your doctor prior to physical activity. 
  
NOTE: If the PAR-Q is being given to a person before he or she participates in a physical activity program or a fitness appraisal, this section may be used for legal or administrative 
purposes. 
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“I have read, understood and completed this questionnaire. Any questions I had were answered to my full satisfaction.” 
 
NAME__________________________________________________________________ 
 
SIGNATURE_____________________________________________________________DATE___________________________________________________
_ 
 
 
SIGNATURE OF PARENT or GUARDIAN____________________________________________________________________ 
 
 
WITNESS____________________________________________________ 
 
 
Note: This physical activity clearance is valid for a maximum of 12 months from the date it is completed and 
becomes invalid if your condition changes so that you would answer YES to any of the seven questions. 
 
 Supported by:     Physical Activity Readiness 
Questionnaire – PAR-Q            
(revised 2006 by CW) 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as part of 
their everyday lives.  The questions will ask you about the time you spent being physically active 
in the last 7 days.  Please answer each question even if you do not consider yourself to be an 
active person.  Please think about the activities you do at work, as part of your house and yard 
work, to get from place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much harder than 
normal.  Think only about those physical activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities like 
heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one of those days? 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
Think about all the moderate activities that you did in the last 7 days.  Moderate activities refer 
to activities that take moderate physical effort and make you breathe somewhat harder than 
normal.  Think only about those physical activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not include 
walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
 
4. How much time did you usually spend doing moderate physical activities on one of those days? 
_____ hours per day 
_____ minutes per day 
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  Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work and at home, 
walking to travel from place to place, and any other walking that you might do solely for 
recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  Include time 
spent at work, at home, while doing course work and during leisure time.  This may include time spent 
sitting at a desk, visiting friends, reading, or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
This is the end of the questionnaire, thank you for participating 
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